1. Relationship between metabolic reprogramming and drug resistance in breast cancer
    Linlin Lv et al, 2022, Frontiers in Oncology CrossRef
  2. Targeting metabolism in breast cancer: How far we can go?
    Jing-Pei Long, 2016, World Journal of Clinical Oncology CrossRef
  3. Metabolic Plasticity in Chemotherapy Resistance
    Maria Andrea Desbats et al, 2020, Frontiers in Oncology CrossRef
  4. Adipose Tissue—Breast Cancer Crosstalk Leads to Increased Tumor Lipogenesis Associated with Enhanced Tumor Growth
    Peter Micallef et al, 2021, International Journal of Molecular Sciences CrossRef
  5. Therapeutic Activity of the Lansoprazole Metabolite 5-Hydroxy Lansoprazole Sulfide in Triple-Negative Breast Cancer by Inhibiting the Enoyl Reductase of Fatty Acid Synthase
    Jenny Beebe et al, 2022, Journal of Medicinal Chemistry CrossRef
  6. Approaches to Measuring the Activity of Major Lipolytic and Lipogenic Enzymes In Vitro and Ex Vivo
    Marek Wilhelm et al, 2022, International Journal of Molecular Sciences CrossRef
  7. Cancer Metabolism: Current Understanding and Therapies
    Jessica L. Counihan et al, 2018, Chemical Reviews CrossRef
  8. Rewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations
    Katherine E. Pendleton et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
  9. FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1
    Luciana Yamamoto de Almeida et al, 2023, Oral Diseases CrossRef
  10. AMPK in Health and Disease
    Gregory R. Steinberg et al, 2009, Physiological Reviews CrossRef